Biohaven Ownership | Who Owns Biohaven?

Biohaven Ownership Summary

Biohaven is owned by 51.67% institutional investors, 9.52% insiders, and 38.81% retail investors. Stifel financial is the largest institutional shareholder, holding 9.39% of BHVN shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 2.70% of its assets in Biohaven shares.

BHVN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Biohaven	51.67%	9.52%	38.81%
Sector	Healthcare Stocks	231.98%	10.74%	-142.72%
Industry	Biotech Stocks	381.47%	10.55%	-292.02%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Stifel financial	9.94M	9.39%	$112.22M
Blackrock funding, inc. /de	9.45M	8.93%	$106.67M
Blackrock	6.17M	7.56%	$214.15M
Janus henderson group	6.98M	7.40%	$260.73M
Suvretta capital management	5.62M	5.49%	$84.36M
State street	5.72M	5.40%	$64.54B
Vanguard group	4.40M	4.15%	$49.63M
Rp management	2.94M	3.11%	$146.74M
Bellevue group	2.80M	2.74%	$42.07M
Fmr	2.43M	2.37%	$36.43M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rp management	2.94M	64.43%	$146.74M
Oracle investment management	673.17K	6.51%	$9.50M
Infinitum asset management	1.70M	4.69%	$25.52M
Stempoint capital lp	1.02M	3.06%	$15.27M
Bison wealth	332.43K	2.74%	$12.42M
5am venture management	478.97K	2.63%	$7.19M
Pfizer	505.64K	2.41%	$5.71M
Qtr family wealth	332.29K	2.37%	$4.99M
Suvretta capital management	5.62M	2.16%	$84.36M
Lion point capital, lp	22.70K	1.94%	$340.73K

Top Buyers

Holder	Shares	% Assets	Change
Stifel financial	9.94M	0.10%	3.33M
Blackrock funding, inc. /de	9.45M	0.00%	1.57M
Vanguard group	4.40M	0.00%	1.52M
State street	5.72M	0.00%	1.46M
Bnp paribas arbitrage, snc	2.09M	0.01%	1.25M

Top Sellers

Holder	Shares	% Assets	Change
Farallon capital management	-	-	-4.81M
Armistice capital	-	-	-2.14M
Perceptive advisors	-	-	-1.49M
Darwin global management	-	-	-1.48M
Voloridge investment management	153.64K	0.01%	-1.29M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	902.57K	0.00%	902.57K	$33.71M
Abrdn	693.45K	0.01%	693.45K	$7.83M
Artal group	306.70K	0.27%	306.70K	$10.65M
Weiss asset management lp	242.12K	0.04%	242.12K	$3.63M
Ieq capital	163.39K	0.01%	163.39K	$1.84M

Sold Out

Holder	Change
Financial gravity asset management	-1.00
Beacon capital management	-1.00
Allspring global investments	-2.00
Southstate	-3.00
Gps wealth strategies group	-5.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	169	-43.48%	54,678,322	-35.28%	51	0.76%	99	-28.26%	37	-51.32%
Sep 30, 2025	286	10.00%	83,525,986	-0.78%	81	1.21%	132	-2.94%	74	10.45%
Jun 30, 2025	268	-3.60%	86,968,877	-2.99%	84	1.10%	138	-2.82%	70	-9.09%
Mar 31, 2025	20	-92.51%	4,003,493	-95.66%	3	0.04%	9	-94.12%	7	-89.23%
Dec 31, 2024	107	-59.62%	28,793,137	-66.29%	30	0.37%	63	-53.33%	20	-73.68%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	3.59M	2.70%	-19.32K
Vanguard Total Stock Mkt Idx Inv	2.83M	2.68%	-62.83K
Vanguard US Total Market Shares ETF	2.43M	2.38%	217.08K
BB Biotech AG Ord	2.80M	2.11%	-
Vanguard Small Cap Index	2.11M	1.99%	-14.23K
iShares Russell 2000 ETF	2.26M	1.70%	2.26M
Fidelity Select Biotechnology	1.97M	1.48%	-100.80K
SPDR® S&P Biotech ETF	1.48M	1.40%	3.29K
Vanguard Small Cap Value Index Inv	1.36M	1.29%	6.87K
American Funds SMALLCAP World A	1.42M	1.07%	286.21K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 17, 2025	Clark George C.	VP, Chief Accounting Officer	Buy	$144.77K
Nov 13, 2025	Bailey Gregory	-	Buy	$3.00M
Nov 13, 2025	CHILDS JOHN W	-	Buy	$25.00M
Nov 13, 2025	Coric Vlad	Chief Executive Officer	Buy	$2.50M
Nov 13, 2025	Coric Vlad	Chief Executive Officer	Buy	$2.50M

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	5	-
2025 Q2	-	-
2025 Q1	4	-
2024 Q4	3	-
2024 Q3	2	-

BHVN Ownership FAQ

Who Owns Biohaven?

Biohaven shareholders are primarily institutional investors at 51.67%, followed by 9.52% insiders and 38.81% retail investors. The average institutional ownership in Biohaven's industry, Biotech Stocks , is 381.47%, which Biohaven falls below.

Who owns the most shares of Biohaven?

Biohaven’s largest shareholders are Stifel financial (9.94M shares, 9.39%), Blackrock funding, inc. /de (9.45M shares, 8.93%), and Blackrock (6.17M shares, 7.56%). Together, they hold 25.88% of Biohaven’s total shares outstanding.

Does Blackrock own Biohaven?

Yes, BlackRock owns 7.56% of Biohaven, totaling 6.17M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 214.15M$. In the last quarter, BlackRock increased its holdings by 446.83K shares, a 7.81% change.

Who is Biohaven’s biggest shareholder by percentage of total assets invested?

Rp management is Biohaven’s biggest shareholder by percentage of total assets invested, with 64.43% of its assets in 2.94M Biohaven shares, valued at 146.74M$.

Who is the top mutual fund holder of Biohaven shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Biohaven shares, with 2.70% of its total shares outstanding invested in 3.59M Biohaven shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools